Arcturus Therapeutics updates financial calendar with upcoming Q2 results release and conference callPUBT·1 day ago, 03:01 PMARCT0.00%
Cut the Earnings Season Noise: From AI Washing to Real Cash in 10 Outlier StocksGlobal Report·2 days ago, 04:12 AMHTFL0.00%ENVA0.00%
The Value Chain Dictates the Outcome: From Defense Platforms to Biotech AggregatorsGlobal Report·Jul 21 at 04:13 AMSMJF0.00%LHX0.00%
Amova Asset Management Americas Inc. Grows Stock Holdings in Arcturus Therapeutics Holdings Inc. $ARCTMarket Beat·Jul 21 at 02:13 AMARCT0.00%
How New Forensics and mRNA Partnerships at Thermo Fisher Scientific (TMO) Have Changed Its Investment StorySimplywall·Jul 15 at 12:12 PMTMO0.00%ARCT0.00%
Biotech Reorganizes While Industrials and Consumer Discretionary Navigate Pricing PressuresGlobal Report·Jul 14 at 06:47 AMARCT0.00%MTNB0.00%
How Investors May Respond To Thermo Fisher Scientific (TMO) Deepening Its Role In Late‑Stage mRNA ManufacturingSimplywall·Jul 5 at 03:01 PMTMO0.00%ARCT0.00%
Thermo Fisher, Arcturus partner on Phase III ARCT-032 cystic fibrosis trialWorldPharmaceuticals·Jul 3 at 04:43 AMTMO0.00%ARCT0.00%
Arcturus Therapeutics partners with Thermo Fisher to support Phase 3 development of cystic fibrosis therapy ARCT-032PUBT·Jul 2 at 06:00 AMARCT0.00%TMO0.00%
